Liver cancer

You are here: 

Treatments for stage B liver cancer

The following are treatment options for stage B liver cancer. Your healthcare team will suggest treatments based on your needs and work with you to develop a treatment plan.

Transarterial chemoembolization (TACE)

TACE is a treatment that blocks the blood supply to a liver tumour and delivers chemotherapy directly to the tumour. It is the standard treatment for people who have good liver function, have a good performance status and do not have increased pressure in the portal vein (called portal hypertension).

Targeted therapy

Targeted therapy uses drugs to target specific molecules (such as proteins) on the surface of cancer cells. These molecules help send signals that tell cells to grow or divide. By targeting these molecules, the drugs stop the growth and spread of cancer cells while limiting harm to normal cells. The targeted therapy drug used for stage B liver cancer is sorafenib (Nexavar).

Targeted therapy may be offered if you cannot have TACE because you have poor liver function or portal hypertension, or if TACE did not work.

Clinical trials

You may be asked if you want to join a clinical trial for liver cancer. Find out more about clinical trials.

Stories

Dr Shawn Li I’m extremely grateful to the Canadian Cancer Society for funding my research with an Innovation Grant.

Read more

Great progress has been made

Icon - arrow

Some cancers, such as thyroid and testicular, have survival rates of over 90%. Other cancers, such as pancreatic, brain and esophageal, continue to have very low survival rates.

Learn more